Tag: option

AB Ignitis grupė (hereinafter – the Group) will release its 6M 2025 results on Wednesday, 13 August 2025. It will be followed by an earnings call for investors and analysts to be held on the same day at 1:00 pm Vilnius / 11:00 am London time.

AB Ignitis grupė (hereinafter – the Group) will release its 6M 2025 results on Wednesday, 13 August 2025. It will be followed by an earnings call for investors and analysts to be held on the same day at 1:00 pm Vilnius / 11:00 am London time.

TAICHUNG CITY, Taiwan, July 29, 2025 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of applications including personal sports equipment, healthcare products, automobile parts, resin systems, and research and development services, today announced the pricing of its public offering of an aggregate 1,250,000 ordinary shares of the Company (the “Offering”). The offering is priced at $4.00 per share (the “Offering Price”).

New Non-Stimulant Supplement Aims to Complement Overnight Wellness Routines with Polyamine-Aligned Botanical Support

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- GraniteShares has announced it will execute a reverse share split for the GraniteShares 2x Short COIN (the “Fund”). The total market value of the shares outstanding will not be affected as a result of the reverse split.

TORONTO, July 29, 2025 (GLOBE NEWSWIRE) -- Ninepoint Partners LP (“Ninepoint”), one of Canada’s leading alternative investment management firms, today announced the upcoming launch of its HighShares ETF suite, the first ETFs in Canada to offer enhanced monthly income from single stock exposure to some of the country’s most iconic companies. A receipt for the initial HighShares ETFs’ preliminary prospectus has been issued by the securities regulators in each of the provinces and territories of Canada.

TORONTO, July 29, 2025 (GLOBE NEWSWIRE) -- Allied Properties Real Estate Investment Trust ("Allied") (TSX: "AP.UN") today announced results for the three months ended June 30, 2025. “Operations in the second quarter were encouraging in all respects,” said Cecilia Williams, President & CEO. “Our leased area increased slightly, our average net rent per square foot held steady, our non-core property sales accelerated, and our balance-sheet management progressed.”

VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (FSE: 7JO0) (the “Company” or “Rakovina”), a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce that its board of directors has approved the grant of an aggregate of 540,000 stock options (the “Options”) to certain consultants, employees, officers and directors of the Company pursuant to the Company’s Long Term Incentive Plan.

22nd Century VLN^® products are the only combustible cigarettes authorized by the FDA as a reduced nicotine content product that comply with the FDA proposed rule